APA (7th ed.) Citation

Wang, S., Chuang, S., & Lee, K. (2014). Efficacy of sorafenib as adjuvant therapy to prevent early recurrence of hepatocellular carcinoma after curative surgery: A pilot study. Hepatology research, 44(5), 523-531. https://doi.org/10.1111/hepr.12159

Chicago Style (17th ed.) Citation

Wang, Shen-Nien, Shih-Cheng Chuang, and King-Teh Lee. "Efficacy of Sorafenib as Adjuvant Therapy to Prevent Early Recurrence of Hepatocellular Carcinoma After Curative Surgery: A Pilot Study." Hepatology Research 44, no. 5 (2014): 523-531. https://doi.org/10.1111/hepr.12159.

MLA (9th ed.) Citation

Wang, Shen-Nien, et al. "Efficacy of Sorafenib as Adjuvant Therapy to Prevent Early Recurrence of Hepatocellular Carcinoma After Curative Surgery: A Pilot Study." Hepatology Research, vol. 44, no. 5, 2014, pp. 523-531, https://doi.org/10.1111/hepr.12159.